ALOX5 and benign prostatic hyperplasia: On these bases, the therapeutic use of Ser-Se-Ly—which shows an inhibitory effect on the expression of COX-2, 5-LOX and iNOS [23], and on the mean PSA value [18]—has a role in counteracting inflammation in BPH; thus confirming the role of the association of phytotherapeutics (Ser-Se-Ly) in decreasing the production of inflammatory mediators [24].